Fig. 1
From: Reduction in number to treat versus number needed to treat
NNT vs RNT with perturbation-resampling CIs for the S0226 trial [21]. a Kaplan-Meier estimates of progression-free survival curves for the fulvestrant plus anastrozole therapy and anastrozole therapy alone; b NNTs and RNTs calculated from survival rates with the 95% CIs